Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
Launched by INDIANA UNIVERSITY · Mar 25, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a substance called trypsinogen found in urine can help doctors detect a condition known as post-pancreatectomy acute pancreatitis (PPAP) in patients who have had surgery to remove part or all of their pancreas. The goal is to see if measuring trypsinogen can make it easier to diagnose this condition early, which can help with treatment.
To participate in this study, you must be at least 18 years old and scheduled for elective surgery to remove part of your pancreas. Unfortunately, people who are younger than 18, pregnant women, or prisoners cannot participate. During the trial, your urine will be tested using dipsticks both during and after your surgery to check for trypsinogen levels. This study is not yet recruiting participants, but it aims to improve care for patients undergoing this type of surgery by providing better tools for early diagnosis of complications.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older than 18 years of age
- • Undergoing elective pancreatectomy for any indication
- Exclusion Criteria:
- • Younger than 18 years of age
- • Pregnant women
- • Prisoner
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported